Hemin Side Effects
Medically reviewed by Drugs.com. Last updated on Sep 8, 2024.
Applies to hemin: intravenous powder for solution.
Common side effects of hemin
Some side effects of hemin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
Less common side effects
Incidence not known
- dry, red, hot, or irritated skin
Serious side effects of hemin
Along with its needed effects, hemin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking hemin:
Less common side effects
Incidence not known
For healthcare professionals
Applies to hemin: intravenous powder for injection.
General adverse events
The most frequently reported adverse reactions included headache, pyrexia, infusion site reactions, and phlebitis.[Ref]
Cardiovascular
- Very common (10% or more): Poor venous access
- Common (1% to 10%): Phlebitis
- Uncommon (0.1% to 1%): Venous thrombosis[Ref]
Phlebitis with or without leukocytosis and with or without mild pyrexia was observed after administration of this drug through small arm veins.[Ref]
Dermatologic
- Common (1% to 10%): Rash, cellulitis
- Frequency not reported: Dermatitis medicamentosa[Ref]
Gastrointestinal
- Frequency not reported: Tongue edema
Hematologic
- Frequency not reported: Leukocytosis
- Postmarketing reports: Thrombocytopenia, coagulopathy, hemolysis[Ref]
Coagulopathy included prolonged prothrombin time and prolonged partial thromboplastin time.[Ref]
Hypersensitivity
- Rare (0.01% to 0.1%): Anaphylactoid reaction, hypersensitivity[Ref]
Hypersensitivity reactions included a report of an infusion-related anaphylactoid reaction presenting as circulatory collapse.[Ref]
Local
- Common (1% to 10%): Injection site phlebitis, infusion site pain, infusion site swelling
- Uncommon (0.1% to 1%): Injection site thrombosis
- Frequency not reported: Infusion site erythema, infusion site bleeding, infusion site extravasation[Ref]
Metabolic
- Postmarketing reports: Iron overload[Ref]
Nervous system
- Common (1% to 10%): Headache
Other
- Common (1% to 10%): Pyrexia, catheter-related complications
- Uncommon (0.1% to 1%): Increased serum ferritin
Catheter-related complications included erythema, pain, bleeding, extravasation, and infusion site swelling.
Increased serum ferritin concentration has been reported after several years of treatment with repeated infusions, which may indicate an iron overload.
Renal
- Postmarketing reports: Reversible renal shutdown[Ref]
Reversible renal shutdown has been observed after the administration of excessive doses (12.2 mg/kg).[Ref]
References
1. (2023) "Product Information. Normosang (hemin)." Imported (France)
2. (2020) "Product Information. Panhematin (hemin)." Recordati Rare Diseases Inc
3. (2001) "Product Information. Panhematin (hemin)." Recordati Rare Diseases Inc
4. Cerner Multum, Inc. "UK Summary of Product Characteristics."
More about hemin
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: miscellaneous uncategorized agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Hemin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.